CY1274A - 3-indolyl-tertiary butylaminopropanols - Google Patents

3-indolyl-tertiary butylaminopropanols Download PDF

Info

Publication number
CY1274A
CY1274A CY1274A CY127478A CY1274A CY 1274 A CY1274 A CY 1274A CY 1274 A CY1274 A CY 1274A CY 127478 A CY127478 A CY 127478A CY 1274 A CY1274 A CY 1274A
Authority
CY
Cyprus
Prior art keywords
compound
formula
indolyl
alkyl
scheme
Prior art date
Application number
CY1274A
Other languages
English (en)
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of CY1274A publication Critical patent/CY1274A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CY1274A 1977-07-13 1978-07-10 3-indolyl-tertiary butylaminopropanols CY1274A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81513877A 1977-07-13 1977-07-13

Publications (1)

Publication Number Publication Date
CY1274A true CY1274A (en) 1985-03-08

Family

ID=25216976

Family Applications (1)

Application Number Title Priority Date Filing Date
CY1274A CY1274A (en) 1977-07-13 1978-07-10 3-indolyl-tertiary butylaminopropanols

Country Status (30)

Country Link
JP (1) JPS5419972A (enrdf_load_stackoverflow)
AR (1) AR225274A1 (enrdf_load_stackoverflow)
AT (1) AT364821B (enrdf_load_stackoverflow)
AU (1) AU525064B2 (enrdf_load_stackoverflow)
BE (1) BE868943A (enrdf_load_stackoverflow)
CA (1) CA1116598A (enrdf_load_stackoverflow)
CH (1) CH642066A5 (enrdf_load_stackoverflow)
CY (1) CY1274A (enrdf_load_stackoverflow)
DE (1) DE2830884A1 (enrdf_load_stackoverflow)
DK (1) DK156568C (enrdf_load_stackoverflow)
ES (1) ES471674A1 (enrdf_load_stackoverflow)
FI (1) FI69835C (enrdf_load_stackoverflow)
FR (1) FR2397404A1 (enrdf_load_stackoverflow)
GB (1) GB2001633B (enrdf_load_stackoverflow)
GR (1) GR74488B (enrdf_load_stackoverflow)
HK (1) HK1385A (enrdf_load_stackoverflow)
HU (1) HU178992B (enrdf_load_stackoverflow)
IE (1) IE47122B1 (enrdf_load_stackoverflow)
IL (1) IL55115A (enrdf_load_stackoverflow)
IT (1) IT1105091B (enrdf_load_stackoverflow)
KE (1) KE3485A (enrdf_load_stackoverflow)
LU (1) LU79966A1 (enrdf_load_stackoverflow)
MY (1) MY8500946A (enrdf_load_stackoverflow)
NL (1) NL189946C (enrdf_load_stackoverflow)
NO (1) NO149311C (enrdf_load_stackoverflow)
NZ (1) NZ187763A (enrdf_load_stackoverflow)
SE (1) SE429339B (enrdf_load_stackoverflow)
SG (1) SG82584G (enrdf_load_stackoverflow)
YU (1) YU40528B (enrdf_load_stackoverflow)
ZA (1) ZA783744B (enrdf_load_stackoverflow)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2463765A1 (fr) * 1979-08-17 1981-02-27 Clin Midy Nouveaux derives de l'indole actifs sur le systeme cardiovasculaire
US4321398A (en) * 1981-05-07 1982-03-23 Mead Johnson & Company Thienyl and benzothienyl-tertiary butylaminophenoxypropanols
DE3119796A1 (de) * 1981-05-19 1982-12-23 Hoechst Ag, 6000 Frankfurt Substituierte tryptaminderivate von thienyloxpropanolaminen, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen sowie ihre verwendung
FR2523964B1 (fr) * 1982-03-23 1985-09-27 Sanofi Sa Nouveaux derives de la tryptamine actifs notamment sur le systeme cardiovasculaire et procede pour leur preparation
NZ208337A (en) * 1983-06-10 1988-10-28 Bristol Myers Co 2-(2-hydroxy-3-((2-(ar-hydroxy-1h-aminopropoxy-yl)ethyl benzonitriles and pharmaceutical compositions
FR2601008B1 (fr) * 1986-07-03 1990-03-30 Sanofi Sa Procede de synthese stereospecifique de derives de l'indole
ATE329901T1 (de) 2000-11-10 2006-07-15 Lilly Co Eli 3-substituierte oxindolderivate als beta-3- agonisten
WO2003016307A1 (en) * 2001-08-14 2003-02-27 Eli Lilly And Company β3 ADRENERGIC AGONISTS
DE60211199T2 (de) 2001-08-14 2007-02-01 Eli Lilly And Co., Indianapolis 3-substituierte oxindol-beta-3-agonisten
JP2005518357A (ja) 2001-11-20 2005-06-23 イーライ・リリー・アンド・カンパニー ベータ３アドレナリンアゴニスト
EP1448560B1 (en) 2001-11-20 2005-06-15 Eli Lilly And Company 3-SUBSTITUTED OXINDOLE beta 3 AGONISTS
AU2002357084A1 (en) 2002-01-11 2003-07-30 Eli Lilly And Company 2-oxo-benzimidazolyl substituted ethanolamine derivatives and their use as beta3 agonists
CA2960254A1 (en) 2008-08-01 2010-02-04 Arca Biopharma, Inc. Methods and compositions involving (s)-bucindolol

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1532210A (fr) * 1963-06-21 1968-07-12 Ici Ltd Composés hétérocycliques et leur procédé de préparation
CH495983A (de) * 1968-02-09 1970-09-15 Sandoz Ag Verfahren zur Herstellung von linksdrehendem 4-(2-Hydroxy-3-isopropylaminopropoxy)indol
US3371098A (en) * 1966-11-29 1968-02-27 Philips Corp 5- and 6-methoxy-3-(phenoxyethyl-aminoethyl)-indoles
US3946009A (en) * 1972-05-05 1976-03-23 Merck Sharp & Dohme (I.A.) Corporation 2-(3-Substituted amino-2-hydroxypropoxy)-3-substituted pyrazines

Also Published As

Publication number Publication date
BE868943A (fr) 1979-01-12
AU525064B2 (en) 1982-10-21
CA1116598A (en) 1982-01-19
SE429339B (sv) 1983-08-29
DK156568B (da) 1989-09-11
IL55115A (en) 1981-09-13
FR2397404B1 (enrdf_load_stackoverflow) 1982-06-11
AU3770478A (en) 1980-01-10
CH642066A5 (de) 1984-03-30
HU178992B (en) 1982-07-28
DK156568C (da) 1990-02-05
GB2001633B (en) 1982-03-24
ZA783744B (en) 1979-07-25
GR74488B (enrdf_load_stackoverflow) 1984-06-28
NO782407L (no) 1979-01-16
NZ187763A (en) 1984-07-31
NL189946B (nl) 1993-04-16
SG82584G (en) 1985-09-13
KE3485A (en) 1985-01-25
HK1385A (en) 1985-01-11
IL55115A0 (en) 1978-09-29
YU161178A (en) 1983-02-28
DE2830884A1 (de) 1979-02-01
FI782205A7 (fi) 1979-01-14
NL7807564A (nl) 1979-01-16
IT1105091B (it) 1985-10-28
IE781400L (en) 1979-01-13
JPS6340784B2 (enrdf_load_stackoverflow) 1988-08-12
AR225274A1 (es) 1982-03-15
SE7807700L (sv) 1979-01-14
MY8500946A (en) 1985-12-31
FI69835B (fi) 1985-12-31
DE2830884C2 (enrdf_load_stackoverflow) 1990-01-11
NO149311B (no) 1983-12-19
NL189946C (nl) 1993-09-16
ATA508978A (de) 1981-04-15
IE47122B1 (en) 1983-12-28
IT7850228A0 (it) 1978-07-10
DK313878A (da) 1979-01-14
FI69835C (fi) 1986-05-26
FR2397404A1 (fr) 1979-02-09
GB2001633A (en) 1979-02-07
AT364821B (de) 1981-11-25
YU40528B (en) 1986-02-28
LU79966A1 (fr) 1979-04-09
NO149311C (no) 1984-03-28
ES471674A1 (es) 1979-10-01
JPS5419972A (en) 1979-02-15

Similar Documents

Publication Publication Date Title
EP0196222B1 (en) Hypoglycemic agent
US4234595A (en) 3-Indolyl-tertiary butylaminopropanols
SU1248533A3 (ru) Способ получени сульфамоилзамещенных производных фенэтиламина или его сол нокислой соли
JPS5840956B2 (ja) アミノアルキルフラン誘導体、その製法およびそれを含有する医薬組成物
CY1274A (en) 3-indolyl-tertiary butylaminopropanols
EP0047536B1 (en) Substituted propylamines
IE44904B1 (en) Aminophosphonous acids and processes for their preparation
US4081547A (en) Para-polyfluoroisopropyl-anilino-2-oxazoline compounds, pharmaceutical compositions and method of treating hypertension
RU2056416C1 (ru) Производные тиомочевины, фармацевтическая композиция и способ лечения
GB2107714A (en) Phenyl ketones
JPS6334865B2 (enrdf_load_stackoverflow)
EP0150235A1 (en) Derivatives of 3-pyrrolidinopropiophenone and a process for preparation thereof
EP0105458B1 (en) Alpha-aryl-alpha-pyridylalkanoic acid derivatives, process for preparation thereof and pharmaceutical composition comprising the same
US4206217A (en) 3-[4-(1,3-Diazacycloalken-2-yl)-phenyl]-1,2-benzisothiazoles, their manufacture, and drugs containing these compounds
HU178147B (en) Process for producing hexahydro-1,4-oxazepines
KR850000210B1 (ko) 옥사졸린의 제조방법
GB2074576A (en) 1-(acylamino-aryloxy)-3-alkylamino-propan-2-ols processes for their preparation and pharmaceutical compositions containing them
US4259257A (en) 1-Phenyl-2-amino-1,3-propanediol-N-aryloxyalkyl derivatives
KR940001777B1 (ko) N-메톡시페닐에틸-n'-이미다졸릴페닐아미딘 유도체 및 그의 제조방법
KR820001447B1 (ko) 3-인돌릴-3급 부틸아미노프로판올의 제조방법
GB2068963A (en) Basic ethers of 4-hydroxy-benzophenones acting as beta-blocking agents and relevant preparation processes
SK143697A3 (en) A process for preparing form 1 ranitidine hydrochloride
EP0058009A1 (en) Novel benzanilide derivatives and pharmaceutical compositions containing them
HU196584B (en) Process for producing 4-phenyl-2-oxo-2-butenoic acid derivatives and pharmaceutics comprising such active ingredient
US4980352A (en) Gem-dimethyl substituted bicyclic compounds useful as eukalemic diuretics